UCHealth Dermatology Clinic - Anschutz Medical Campus
1665 Aurora Ct, 3rd Floor, Anschutz Cancer Pavilion Aurora, CO 80045Phone: 720-848-0500
Brad Haverkos, MD
Hematology and Oncology
Board Certified
Clinical Interest for Patients
My clinical interests include the treatment and management of lymphoma patients with a specific interest in T-cell lymphomas.
Credentials
Doctor of Medicine
Specialty
Internal Medicine, Hematology and Oncology
Scheduling Phone Number
720-848-6400
Gender
Male
Languages
English
Hospital Affiliation
University of Colorado Hospital
UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus
12605 E. 16th Ave Aurora, CO 80045Phone: 720-848-0000
Provider Information
Specialties
- Internal Medicine
- Hematology and Oncology (2012)
Conditions
-
Cancers
Lymphoma , Blood and Marrow Transplant
Interests and Activities
Personal Interests
Dr. Haverkos completed his bachelor’s degree at Miami University in Ohio. This was followed by receipt of a combined MD/MPH degree at Wright State University in Dayton, Ohio as part of the Boonshoft School of Medicine Physician Leadership Development Program. He moved to the University of Illinois in Chicago for his residency in Internal Medicine.
He then completed his fellowship training in Hematology and Oncology at Ohio State University, where he also completed a Master’s degree in Medical Science and a NIH sponsored post-doctoral fellowship with an emphasis on immunology, virology, biostatistics, and clinical trial design. In 2015 he joined the lymphoma and BMT program at the University of Colorado.
Dr. Haverkos is a principal investigator of multiple early-phase clinical trials. He has published and presented his research at the national and international level. He also serves as a reviewer for a number of medical journals and is a member on multiple professional organizations.
Department
Associate Professor, Medicine-Hematology
Research and Grants
Research Interests for Patients
Dr. Haverkos’ research focuses on developing novel management and treatment strategies in aggressive lymphoma subtypes with a focus on mature T and NK cell lymphoproliferative disorders (LPDs), including T-cell lymphomas. He collaborates with multiple laboratories with the goal of improving our understanding on the etiopathogenesis of T and NK/T-cell LPDs. He aims to translate discoveries grounded in this translational research into early phase clinical trials, which will lead to better patient outcomes. Recently, his research efforts center on identifying markers that prognosticate and predict response to specific therapies. He is also interested in improving clinical practice guidelines for patients with blood cancers.
Education and Training
Medical Schools
MD, Wright State University Boonshoft School of Medicine (2009)
Undergraduate Schools
BA, Miami University of Ohio (OH) (2003)
Graduate Schools
MPH, Wright State University (2009)
MS, Ohio State University, The (2015)
Residency Program
University of Illinois College of Medicine at Chicago Program (2012)
Fellowships
Ohio State University Hospital Program (2015)
Information for referring providers
Referral Contact Phone
720-848-6400